@werner_brouwer @nancydevlin1 @Basucally @PeterNeumann11 @djvanness @AnkurFactorial @GSchmidler Not sure it ever changed. Was a suggestion in 2014 that was consulted on and finally published In that doc Nance linked. They had previously made it higher by w
RT @HPRU_EI: In 2018, a panel of experts met in London to review the #economicevaluation of meningococcal #vaccines. This paper by @HPRU_EI…
RT @HajBrum: nice to be part of this collaboration - thinking about tricky issues in valuing vaccines including peace of mind and family i…
RT @HPRU_EI: In 2018, a panel of experts met in London to review the #economicevaluation of meningococcal #vaccines. This paper by @HPRU_EI…
In 2018, a panel of experts met in London to review the #economicevaluation of meningococcal #vaccines. This paper by @HPRU_EI's @Christensen_H summarises what was discussed, agreed on & recommendations made. https://t.co/WkrBKChiVg #meningitis #heal
RT @javierdiezd: Transparency in the vaccine decision-making process is beneficial and should be implemented when posible. One of the great…
RT @PaulaLorgelly: Economic evaluations of meningococcal vaccines, how to future proof. New article led by Hannah Christensen of @BrisPopHe…
RT @PaulaLorgelly: Economic evaluations of meningococcal vaccines, how to future proof. New article led by Hannah Christensen of @BrisPopHe…
RT @PaulaLorgelly: Economic evaluations of meningococcal vaccines, how to future proof. New article led by Hannah Christensen of @BrisPopHe…
nice to be part of this collaboration - thinking about tricky issues in valuing vaccines including peace of mind and family impact
Economic evaluations of meningococcal vaccines, how to future proof. New article led by Hannah Christensen of @BrisPopHealth with @HajBrum, @koonalshah, myself and others in collaboration with @M_R_F #meningitis https://t.co/cw7y0FOHRq
@AIVFisabio @GVAfisabio @alejandroorrico #Meningococcal #disease is highly unpredictable over time a key challenge is how to incorporate that unpredictability into a #MathematicalModel. i.e. Analysis of the impact of #MeningococcalVaccine is complex https
RT @javierdiezd: Transparency in the vaccine decision-making process is beneficial and should be implemented when posible. One of the great…
RT @javierdiezd: Transparency in the vaccine decision-making process is beneficial and should be implemented when posible. One of the great…
RT @javierdiezd: Transparency in the vaccine decision-making process is beneficial and should be implemented when posible. One of the great…
RT @javierdiezd: Transparency in the vaccine decision-making process is beneficial and should be implemented when posible. One of the great…
Transparency in the vaccine decision-making process is beneficial and should be implemented when posible. One of the great tips in this paper. Obvious but... https://t.co/X98jKb8wrT #vaccines https://t.co/rwMSZWbFSY
#HealthEconJA Economic evaluation of meningococcal vaccines: considerations for the future https://t.co/B6yZi0YWkG